In the last week, Pharma has been flat. As for the the longer term, the industry is up 3.3% over the past 12 months. In the next few years, earnings are forecast to decline by 17% annually.
Has the Malaysian Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sat, 15 Jun 2024 | RM4.6b | RM2.6b | RM541.3m | 13.4x | 8.4x | 1.7x |
Mon, 13 May 2024 | RM4.9b | RM2.6b | RM559.3m | 12.4x | 8.7x | 1.9x |
Wed, 10 Apr 2024 | RM4.6b | RM2.6b | RM559.3m | 12.3x | 8.1x | 1.7x |
Fri, 08 Mar 2024 | RM4.5b | RM2.6b | RM559.3m | 12.6x | 8.1x | 1.7x |
Sun, 04 Feb 2024 | RM4.5b | RM2.6b | RM584.9m | 12.1x | 7.7x | 1.8x |
Tue, 02 Jan 2024 | RM4.3b | RM2.6b | RM584.9m | 12.4x | 7.3x | 1.7x |
Thu, 30 Nov 2023 | RM4.1b | RM2.6b | RM587.2m | 12.3x | 7.1x | 1.6x |
Sat, 28 Oct 2023 | RM4.2b | RM2.6b | RM604.4m | 12x | 7x | 1.6x |
Mon, 25 Sep 2023 | RM4.3b | RM2.6b | RM604.4m | 12.8x | 7.1x | 1.7x |
Wed, 23 Aug 2023 | RM4.4b | RM2.6b | RM304.2m | 14.2x | 14.5x | 1.7x |
Fri, 21 Jul 2023 | RM4.3b | RM2.6b | RM304.7m | 14.4x | 14.3x | 1.7x |
Sun, 18 Jun 2023 | RM4.4b | RM2.6b | RM304.7m | 14.2x | 14.3x | 1.7x |
Tue, 16 May 2023 | RM4.6b | RM2.5b | RM289.8m | 13.4x | 15.9x | 1.8x |
Thu, 13 Apr 2023 | RM4.8b | RM2.5b | RM289.8m | 13.5x | 16.5x | 1.9x |
Sat, 11 Mar 2023 | RM4.8b | RM2.5b | RM289.8m | 13.6x | 16.4x | 1.9x |
Mon, 06 Feb 2023 | RM4.6b | RM2.4b | RM270.7m | 13.3x | 16.9x | 1.9x |
Wed, 04 Jan 2023 | RM4.8b | RM2.4b | RM270.7m | 13.1x | 17.7x | 2x |
Fri, 02 Dec 2022 | RM4.5b | RM2.4b | RM268.1m | 12.7x | 16.6x | 1.8x |
Sun, 30 Oct 2022 | RM4.0b | RM2.4b | RM249.0m | 11.7x | 16.2x | 1.7x |
Tue, 27 Sep 2022 | RM3.9b | RM2.4b | RM249.0m | 11.5x | 15.5x | 1.6x |
Thu, 25 Aug 2022 | RM3.9b | RM2.4b | RM245.2m | 11.7x | 16x | 1.6x |
Sat, 23 Jul 2022 | RM3.8b | RM2.3b | RM226.0m | 13.6x | 16.9x | 1.7x |
Mon, 20 Jun 2022 | RM3.5b | RM2.3b | RM226.0m | 13.9x | 15.6x | 1.5x |
Wed, 18 May 2022 | RM3.9b | RM2.2b | RM204.5m | 16.2x | 19.3x | 1.8x |
Fri, 15 Apr 2022 | RM4.0b | RM2.2b | RM204.5m | 16.6x | 19.7x | 1.8x |
Sun, 13 Mar 2022 | RM3.7b | RM2.2b | RM204.5m | 15.7x | 18.1x | 1.7x |
Tue, 08 Feb 2022 | RM3.6b | RM2.1b | RM187.4m | 15.9x | 19.5x | 1.7x |
Thu, 06 Jan 2022 | RM3.7b | RM2.1b | RM187.4m | 15.8x | 19.9x | 1.7x |
Sat, 04 Dec 2021 | RM3.7b | RM2.1b | RM187.4m | 14.9x | 19.7x | 1.7x |
Mon, 01 Nov 2021 | RM3.8b | RM2.0b | RM166.6m | 20.4x | 22.9x | 1.9x |
Wed, 29 Sep 2021 | RM4.0b | RM2.0b | RM166.5m | 20.4x | 23.9x | 2x |
Fri, 27 Aug 2021 | RM4.1b | RM2.0b | RM166.5m | 20x | 24.3x | 2x |
Sat, 03 Jul 2021 | RM4.5b | RM2.0b | RM166.5m | 20.2x | 26.9x | 2.2x |
26.9x
How does Malaysian Pharma compare with similar industries?
MY Market | 1.15% | |
Healthcare | 3.05% | |
Pharma | 0.57% | |
Pharma | 0.57% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
RHONEMA Rhone Ma Holdings Berhad | RM0.69 | 4.5% +RM6.6m | -4.8% | PE12.5x |